ABCB1 and cancer: In addition, in vivo studies indicated the high accumulation of folate-modified liposomes in tumors (around 15–18%), followed by an efficient downregulation of the MDR1 gene and p-glycoprotein expression (to 40% of the control group) in tumors, indicating the great potential of this formulation for cancer treatment [109].